⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

RLYB News

Rallybio Corporation Common Stock

Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study